Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675151 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
A Phase 2 study, sponsored by Ocuphire Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT04675151 is a Phase 2 study that has completed, run by Ocuphire Pharma. The registered enrollment target is 150 participants.
The verdict
NCT04675151, a Phase 2 study, has completed, sponsored by Ocuphire Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The objectives of this study are: To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia
Interventions
- OTHER Placebo
- DRUG Pilocarpine
- DRUG Phentolamine Ophthalmic Solution 0.75%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04675151
The ClinicalTrials.gov registry entry for NCT04675151 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ocuphire Pharma, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04675151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04675151 about?
NCT04675151 is a clinical study titled "Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia". The objectives of this study are: To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia
What is the current status of trial NCT04675151?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2021-02-15. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04675151?
The interventions under investigation include: Placebo (OTHER), Pilocarpine (DRUG), Phentolamine Ophthalmic Solution 0.75% (DRUG).
Who is sponsoring clinical trial NCT04675151?
This trial is sponsored by Ocuphire Pharma, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.